All In MedTech

Device Trial Radar · NCT04293861

Evaluation of the Evolution of Biological and Imaging Markers of Bone and Cartilage Degradation in Patients With Knee Osteoarthritis Receiving Intra-articular Injections of a Hyaluronan Derivative HYMOVIS®

Last checked: Nov 20, 2026Latest source record: Mar 6, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Apr 1, 2015

Primary completion

Jun 6, 2017

Study completion Jun 6, 2017

Sponsor

Lead sponsor
Fidia Farmaceutici s.p.a.Not on our public-company list
Sponsor type
Industry
First posted
Mar 3, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot study MOKHA is aimed to evaluate the beneficial effect of HYMOVIS® on cartilage of patients suffering of knee osteoarthritis as revealed by using scientifically sound, objective measurements of biological and MRI-based imaging markers.

Conditions

  • Knee Osteoarthritis

Interventions

  • HYMOVISDevice

    HYMOVIS is a clear hydrogel obtained by hydration of the HA-based derivative named HYADD4p5. The conjugate compound is constituted by a partial hexadecylamide of hyaluronic acid, which is produced by a fermentation process.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assess the variation of type II collagen-specific biomarkers (Coll2-1, Coll2-1NO2 & CTX-II) after HYMOVIS® treatment versus baselineTime frame: Variation of levels of biomarkers from baseline (V1) trough 1 year follow up (V8)

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Service de Rhumatologie, CHU Brugmann

    Brussels, Belgium

  • CHR Citadelle de Liège

    Liège, Belgium

  • Service de Rhumatologie CHU Liège

    Liège, Belgium

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.